Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from “neutral” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $56 to $69. Cubist's shares closed at $57.00 yesterday.

Analysts at Benchmark upgraded Open Text (NASDAQ: OTEX) from “hold” to “buy.” The target price for Open Text is set to $85. Open Text's shares closed at $67.46 yesterday.

Analysts at Piper Jaffray upgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from “neutral” to “overweight.” The target price for Questcor Pharmaceuticals has been raised from $41 to $74. Questcor's shares closed at $51.91 yesterday.

Analysts at JP Morgan upgraded Compass Minerals International (NYSE: CMP) from “underweight” to “neutral” The target price for Compass Minerals International has been raised from $65 to $66. Compass Minerals International's shares closed at $73.06 yesterday.